Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)
China flag China · Delayed Price · Currency is CNY
4.080
-0.010 (-0.25%)
Mar 10, 2026, 3:04 PM CST

Hunan Er-Kang Pharmaceutical Company Description

Hunan Er-Kang Pharmaceutical Co., Ltd engages in the research and development, production, and sale of pharmaceutical excipients, APIs and finished drugs in China and internationally.

The company offers various APIs, such as glycerin, dilute hydrochloric acid, sulbenicillin sodium, dihydroxypropyl theophylline, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol.

It also provides finished drugs, including sulbenicillin sodium for injection and compound liquorice tablets.

In addition, the company offers conventional pharmaceutical excipients include pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose; and new pharmaceutical excipients comprise hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate products.

Hunan Er-Kang Pharmaceutical Co., Ltd was founded in 2003 and is based in Changsha, China.

Hunan Er-Kang Pharmaceutical Co., Ltd
Country China
Founded 2003
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,453
CEO Qingrong Sun

Contact Details

Address:
No. 1
Changsha, Hunan Province 410331
China
Phone 86 731 8465 9108
Website hnerkang.com

Stock Details

Ticker Symbol 300267
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100001781
SIC Code 2834

Key Executives

Name Position
Qingrong Sun GM and Non-Independent Director
Zhao Xun Chief Financial Officer and Non Independent Director
Xiangyang Shi Deputy GM and Non Independent Director
Jishun Gu Deputy GM and Board Secretary
Licheng Zhang Deputy General Manager
Yuhua Kuang Accounting Supervisor
Jiang Xiao Chief Engineer